drugset
drugset / Trial / NCT03655080

Pulsed Abraxane and Radiotherapy for Improving and Maintaining Ambulation After Cancer-Related Cord Compression

NCT03655080 ↗

Phase 2 Terminated 2 enrolled Washington University School of Medicine Celgene Corporation · collab
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this research study is to look at a combination treatment of radiation therapy and a drug called Abraxane to treat epidural spinal cord compression.

Timeline

Start
2019-01-09
Primary completion
2021-02-22
Completion
2021-06-15

Outcome

Outcome not reported

Stopped: “Pharmaceutical company decided to close study”

Drugs

EvaluationDrugModalityDoseRoute
Subject Nab-paclitaxel Small molecule 15 mg/m2 Intravenous

Indications

nerve compression syndrome